Conservest Capital Advisors Inc. Makes New Investment in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Conservest Capital Advisors Inc. bought a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 5,497 shares of the company’s stock, valued at approximately $447,000.

Other large investors also recently added to or reduced their stakes in the company. Raymond James Financial Services Advisors Inc. grew its position in shares of VanEck Pharmaceutical ETF by 462.4% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 18,148 shares of the company’s stock valued at $1,477,000 after purchasing an additional 14,921 shares during the last quarter. Private Client Services LLC bought a new position in shares of VanEck Pharmaceutical ETF in the fourth quarter worth about $298,000. GSA Capital Partners LLP increased its stake in shares of VanEck Pharmaceutical ETF by 12.6% in the third quarter. GSA Capital Partners LLP now owns 13,210 shares of the company’s stock worth $1,055,000 after purchasing an additional 1,480 shares during the period. Allworth Financial LP bought a new position in shares of VanEck Pharmaceutical ETF in the fourth quarter worth about $28,000. Finally, LPL Financial LLC increased its stake in shares of VanEck Pharmaceutical ETF by 60.8% in the third quarter. LPL Financial LLC now owns 65,749 shares of the company’s stock worth $5,251,000 after purchasing an additional 24,850 shares during the period.

VanEck Pharmaceutical ETF Stock Performance

Shares of VanEck Pharmaceutical ETF stock traded up $0.28 during trading on Friday, reaching $86.80. The company’s stock had a trading volume of 616,575 shares, compared to its average volume of 132,669. The business’s fifty day moving average price is $88.64 and its 200-day moving average price is $83.68. The firm has a market cap of $498.23 million, a price-to-earnings ratio of 20.57 and a beta of 0.72. VanEck Pharmaceutical ETF has a one year low of $74.05 and a one year high of $91.16.

VanEck Pharmaceutical ETF Announces Dividend

The firm also recently disclosed a dividend, which was paid on Friday, April 5th. Stockholders of record on Tuesday, April 2nd were paid a $0.5328 dividend. The ex-dividend date of this dividend was Monday, April 1st.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.